| News and New Technologies from the Buyer's Guide for Life Scientists |
Sponsored by Mirus Bio LLC.
TransIT®-2020 Transfection Reagent from Mirus Bio
Mirus Bio has expanded its transfection expertise with the development of TransIT®-2020 – a new and versatile transfection solution for broad spectrum DNA or siRNA delivery into mammalian cells. Developed by Mirus Bio scientists with over 15 years of gene delivery expertise, TransIT®-2020 is a high performance reagent that outperforms major competitors such as Fugene® HD and Lipofectamine™ in many cell types, including hard to transfect cells. Additionally, TransIT®-2020 is animal component free and allows maximum compatibility for all downstream applications. more...
|
|
|
|
| Featured Article
|
Spectrophotometry Spectrophotometry is a technology that has long been considered mature, and advances in instrumentation tend to focus on fine-tuning the technical details, such as...more...
|
|
|
|
|
|
|
|
|
|
|
|
|
| Back to Top |